Agence de la biomédecine - AMP Vigilance, 2023
Abstract
Rapport annuel d'AMP Vigilance 2022 de l'Agence de la biomédecine. ENGLISH
Summary
2022 ART adverse-event surveillance report from the French Agence de la biomédecine, covering serious adverse events and reactions in assisted reproduction during 2022.